XML 24 R12.htm IDEA: XBRL DOCUMENT

Tax Matters	6 Months Ended
Tax Matters	Jun. 28, 2020
Income Tax Disclosure [Abstract]
Tax Matters	Note 4. Tax Matters In the second quarter of 2020, the Company recorded an income tax benefit of approximately $279 thousand, which reflects the jurisdictional mix of income and associated tax rates related to the debt issuances completed in June 2020 (see Note 2E and Note 5B ). This amount is presented as Net transfer—Pfizer in the condensed consolidated statements of equity to reflect the benefit Pfizer will receive from the losses generated by the Company.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details